Showing results (781-790 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|December 14, 2005
Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patientsFrancisco Plancarte, Armando López-Guillermo, Leonor Arenillas, et al.
European Journal of Haematology|December 14, 2005
Hb Woodville, a rare alpha-globin variant, caused by codon 6 mutation of the alpha1 geneVip Viprakasit, Worrawut Chinchang, Pipat Chotimarat
European Journal of Haematology|January 1, 1991
The effect of interleukin-1 on iron metabolism in ratsT Uchida, A Yamagiwa, K Nakamura
European Journal of Haematology|January 1, 1991
Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha 2bC Aul, N Gattermann, W Schneider
European Journal of Haematology|January 1, 1991
Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignanciesP C Huijgens, G J Ossenkoppele, T F Weijers, et al.
European Journal of Haematology|November 10, 2009
Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survivalMrinal M Patnaik, Domenica Caramazza, Naseema Gangat, et al.
European Journal of Haematology|August 1, 1992
Evaluation of bone marrow cellularity by magnetic resonance imaging in patients with myelodysplastic syndromeL Depaoli, O Davini, M D Foggetti, et al.
European Journal of Haematology|August 1, 1992
Effectiveness of partial splenic embolization as treatment for hypersplenism in thalassaemia major: a 7-year follow upA Pinca, A Di Palma, S Soriani, et al.
European Journal of Haematology|August 1, 1992
A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipientsA Shanwell, S Larsson, J Aschan, et al.
European Journal of Haematology|November 7, 2009
Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapseHans B Ommen, Mette Ostergaard, Ming Yan, et al.
Pageof 527